Company news
Marker Therapeutics, Inc. news in 2020
Marker Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Marker Therapeutics Reports Third Quarter 2020 Operating and Financial Results
November 8, 2020
Marker Therapeutics to Host Third Quarter 2020 Operating and Financial Results Conference Call and Webcast on Monday, November 9, 2020
November 1, 2020
Marker Therapeutics to Present at the Virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 16, 2020
Marker Therapeutics Reports Second Quarter 2020 Operating and Financial Results
August 9, 2020
Marker Therapeutics Announces New Manufacturing Facility to Support Clinical Development of MultiTAA-Specific T Cell Therapy Product Candidates
June 29, 2020
Marker Therapeutics Receives USAN Approval for "zelenoleucel" as Nonproprietary Name for MT-401, Multi-Tumor-Associated Antigen Targeted T Cell Product for Acute Myeloid Leukemia
June 22, 2020
Marker Therapeutics Reports Interim Results of its MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at the 2020 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
May 28, 2020
Marker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA-Specific T Cell Therapy in Patients with Pancreatic Adenocarcinoma at ASCO 2020 Annual Meeting
May 12, 2020
Marker Therapeutics Reports First Quarter 2020 Operating and Financial Results
May 10, 2020
Marker Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and Webcast on Monday, May 11, 2020
May 3, 2020
Marker Therapeutics Receives FDA Orphan Drug Designation for its Multi-Antigen Targeted T Cell Therapy for Acute Myeloid Leukemia
April 28, 2020
Marker Therapeutics Reports Full Year 2019 Operating and Financial Results
March 11, 2020
Marker Therapeutics and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $30 million
March 1, 2020
Marker Therapeutics to Present at Two Upcoming Investor Conferences
February 17, 2020
Marker Therapeutics Announces Update to its Clinical Program in AML
February 10, 2020
Decks in 2020
- Technical Presentation (June 2020)
Technical · 40 slides · Jun 1, 2020